“Validation of the therapeutic conduct proposed by artificial intelligence in the context patients with Diabetes mellitus who present hypersensitivity reaction to exogenous insulin ” (2024) Research, Society and Development, 13(11), p. e73131147357. doi:10.33448/rsd-v13i11.47357.